706 related items for PubMed ID: 20887134
1. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
Bellut D, Hlavica M, Schmid C, Bernays RL.
Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
[Abstract] [Full Text] [Related]
2. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[Abstract] [Full Text] [Related]
3. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[Abstract] [Full Text] [Related]
4. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
[Abstract] [Full Text] [Related]
5. Use of high-field intraoperative magnetic resonance imaging during endoscopic transsphenoidal surgery for functioning pituitary microadenomas and small adenomas located in the intrasellar region.
Tanei T, Nagatani T, Nakahara N, Watanabe T, Nishihata T, Nielsen ML, Takebayashi S, Hirano M, Wakabayashi T.
Neurol Med Chir (Tokyo); 2013 Oct; 53(7):501-10. PubMed ID: 23883562
[Abstract] [Full Text] [Related]
6. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H, Fukuhara N, Horiguchi K, Yamada S.
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[Abstract] [Full Text] [Related]
7. Impact of intraoperative MRI-guided transsphenoidal surgery on endocrine function and hormone substitution therapy in patients with pituitary adenoma.
Bellut D, Hlavica M, Muroi C, Woernle CM, Schmid C, Bernays RL.
Swiss Med Wkly; 2012 Sep; 142():w13699. PubMed ID: 23135765
[Abstract] [Full Text] [Related]
8. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M.
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[Abstract] [Full Text] [Related]
9. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M, Motiei-Langroudi R.
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[Abstract] [Full Text] [Related]
10. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C, Oearsakul T.
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[Abstract] [Full Text] [Related]
11. Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations.
Zada G, Cavallo LM, Esposito F, Fernandez-Jimenez JC, Tasiou A, De Angelis M, Cafiero T, Cappabianca P, Laws ER.
Neurosurg Focus; 2010 Oct; 29(4):E8. PubMed ID: 20887133
[Abstract] [Full Text] [Related]
12. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[Abstract] [Full Text] [Related]
13.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
14. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
[Abstract] [Full Text] [Related]
15. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU, Wardlaw SL, Post KD.
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[Abstract] [Full Text] [Related]
16.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
17. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
Wang YY, Higham C, Kearney T, Davis JR, Trainer P, Gnanalingham KK.
Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
[Abstract] [Full Text] [Related]
18. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[Abstract] [Full Text] [Related]
19. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
Berkmann S, Schlaffer S, Nimsky C, Fahlbusch R, Buchfelder M.
J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
[Abstract] [Full Text] [Related]
20. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER.
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
